R. S. Ames, D. Lee, J. J. Foley, A. J. Jurewicz, M. A. Tornetta, W. Bautsch, B. Settmacher, A. Klos, K. F. Erhard, R. D. Cousins, A. C. Sulpizio, J. P. Hieble, G. McCafferty, K. W. Ward, J. L. Adams, W. E. Bondinell, D. C. Underwood, R. R. Osborn, A. M. Badger and H. M. Sarau, “Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models,” The Journal of Immunology, Vol. 166, No. 10, 2001, pp. 6341-6348.

has been cited by the following article:

• TITLE: Anaphylatoxins: From Supposed Toxin Anaphylactics to Effective Mediators of the Early Events of Inflammation

  AUTHORS: Wilmar Dias da Silva

  KEYWORDS: Anaphylatoxins; Inflammation; Innate Immunity

  JOURNAL NAME: Open Journal of Veterinary Medicine, Vol.2 No.4, December 21, 2012

  ABSTRACT: This review updates original data describing the experiments showing the complement origin of anaphylatoxins unexplainable submerged under the surface of the articles related to the subject. Next, recalls subsequent data describing the anaphylatoxins peptide nature and sequences, the cell receptors with which they interact and activate and the outcome of the cell responses. The review continues by highlighting the anaphylatoxin biological properties focusing on the unequivocal participation of these mediators in inflammation. The review concludes bringing data reinforcing the promising use of these peptides as molecular primers to create specific and efficient pharmacological antagonists.